PTPA and Parkinson disease: There were no significant changes in levels of either PP1, PP2A or PP2B between PD and control striata, similar to our findings in A53T transgenic and wild type, again suggesting that alterations in protein phosphatases do not contribute to increases in p-Tau levels.